+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Umbilical Cord Blood Banking - Global Market Trajectory & Analytics

  • ID: 5310767
  • Report
  • April 2021
  • Region: Global
  • Global Industry Analysts, Inc

FEATURED COMPANIES

  • CBR Systems, Inc.
  • Cord Blood America, Inc.
  • CordLife Group Ltd.
  • Cryo-Save AG
  • StemCyte Inc.
  • ViaCord
Global Umbilical Cord Blood Banking Market to Reach $8.2 Billion by 2027

Amid the COVID-19 crisis, the global market for Umbilical Cord Blood Banking estimated at US$4.2 Billion in the year 2020, is projected to reach a revised size of US$8.2 Billion by 2027, growing at a CAGR of 10% over the period 2020-2027. Public Cord Blood Banks, one of the segments analyzed in the report, is projected to record 9.5% CAGR and reach US$2.9 Billion by the end of the analysis period. After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the Private Cord Blood Banks segment is readjusted to a revised 10.3% CAGR for the next 7-year period.





The U.S. Market is Estimated at $1.2 Billion, While China is Forecast to Grow at 9.4% CAGR

The Umbilical Cord Blood Banking market in the U.S. is estimated at US$1.2 Billion in the year 2020. China, the world`s second largest economy, is forecast to reach a projected market size of US$1.4 Billion by the year 2027 trailing a CAGR of 9.4% over the analysis period 2020 to 2027. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 9.3% and 8.2% respectively over the 2020-2027 period. Within Europe, Germany is forecast to grow at approximately 8.1% CAGR.

Select Competitors (Total 42 Featured):
  • CBR Systems, Inc.
  • China Cord Blood Corporation
  • Cord Blood America, Inc.
  • CordLife Group Ltd.
  • Cryo-Cell International, Inc.
  • Cryo-Save AG
  • LifeCell International Pvt., Ltd.
  • StemCyte Inc.
  • ViaCord
  • Vita 34 AG
Frequently Asked Questions about the Global Market for Umbilical Cord Blood Banking

What is the estimated value of the Global Market for Umbilical Cord Blood Banking?

The Global Market for Umbilical Cord Blood Banking was estimated to be valued at $4.2 Billion in 2020.

What is the growth rate of the Global Market for Umbilical Cord Blood Banking?

The growth rate of the Global Market for Umbilical Cord Blood Banking is 10.0%, with an estimated value of $8.2 Billion by 2027.

What is the forecasted size of the Global Market for Umbilical Cord Blood Banking?

The Global Market for Umbilical Cord Blood Banking is estimated to be worth $8.2 Billion by 2027.

Who are the key companies in the Global Market for Umbilical Cord Blood Banking?

Key companies in the Global Market for Umbilical Cord Blood Banking include CBR Systems, Inc., China Cord Blood Corporation, Cord Blood America, Inc., CordLife Group Ltd., Cryo, Cell International, Inc., Cryo, Save AG and StemCyte Inc..
Note: Product cover images may vary from those shown

FEATURED COMPANIES

  • CBR Systems, Inc.
  • Cord Blood America, Inc.
  • CordLife Group Ltd.
  • Cryo-Save AG
  • StemCyte Inc.
  • ViaCord

I. METHODOLOGYII. EXECUTIVE SUMMARY
1. MARKET OVERVIEW
  • Influencer Market Insights
  • World Market Trajectories
  • Impact of Covid-19 and a Looming Global Recession

2. FOCUS ON SELECT PLAYERS3. MARKET TRENDS & DRIVERS
4. GLOBAL MARKET PERSPECTIVE
  • Table 1: World Current & Future Analysis for Umbilical Cord Blood Banking by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR
  • Table 2: World 7-Year Perspective for Umbilical Cord Blood Banking by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2020 & 2027
  • Table 3: World Current & Future Analysis for Public Cord Blood Banks by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR
  • Table 4: World 7-Year Perspective for Public Cord Blood Banks by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2020 & 2027
  • Table 5: World Current & Future Analysis for Private Cord Blood Banks by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR
  • Table 6: World 7-Year Perspective for Private Cord Blood Banks by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2020 & 2027
  • Table 7: World Current & Future Analysis for Cancers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR
  • Table 8: World 7-Year Perspective for Cancers by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2020 & 2027
  • Table 9: World Current & Future Analysis for Blood Disorders by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR
  • Table 10: World 7-Year Perspective for Blood Disorders by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2020 & 2027
  • Table 11: World Current & Future Analysis for Metabolic Disorders by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR
  • Table 12: World 7-Year Perspective for Metabolic Disorders by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2020 & 2027
  • Table 13: World Current & Future Analysis for Immune Disorders by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR
  • Table 14: World 7-Year Perspective for Immune Disorders by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2020 & 2027
  • Table 15: World Current & Future Analysis for Osteopetrosis by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR
  • Table 16: World 7-Year Perspective for Osteopetrosis by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2020 & 2027

III. MARKET ANALYSIS
  • UNITED STATES
  • Table 17: USA Current & Future Analysis for Umbilical Cord Blood Banking by Storage - Public Cord Blood Banks and Private Cord Blood Banks - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
  • Table 18: USA 7-Year Perspective for Umbilical Cord Blood Banking by Storage - Percentage Breakdown of Value Sales for Public Cord Blood Banks and Private Cord Blood Banks for the Years 2020 & 2027
  • Table 19: USA Current & Future Analysis for Umbilical Cord Blood Banking by Application - Cancers, Blood Disorders, Metabolic Disorders, Immune Disorders and Osteopetrosis - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
  • Table 20: USA 7-Year Perspective for Umbilical Cord Blood Banking by Application - Percentage Breakdown of Value Sales for Cancers, Blood Disorders, Metabolic Disorders, Immune Disorders and Osteopetrosis for the Years 2020 & 2027
  • CANADA
  • Table 21: Canada Current & Future Analysis for Umbilical Cord Blood Banking by Storage - Public Cord Blood Banks and Private Cord Blood Banks - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
  • Table 22: Canada 7-Year Perspective for Umbilical Cord Blood Banking by Storage - Percentage Breakdown of Value Sales for Public Cord Blood Banks and Private Cord Blood Banks for the Years 2020 & 2027
  • Table 23: Canada Current & Future Analysis for Umbilical Cord Blood Banking by Application - Cancers, Blood Disorders, Metabolic Disorders, Immune Disorders and Osteopetrosis - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
  • Table 24: Canada 7-Year Perspective for Umbilical Cord Blood Banking by Application - Percentage Breakdown of Value Sales for Cancers, Blood Disorders, Metabolic Disorders, Immune Disorders and Osteopetrosis for the Years 2020 & 2027
  • JAPAN
  • Table 25: Japan Current & Future Analysis for Umbilical Cord Blood Banking by Storage - Public Cord Blood Banks and Private Cord Blood Banks - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
  • Table 26: Japan 7-Year Perspective for Umbilical Cord Blood Banking by Storage - Percentage Breakdown of Value Sales for Public Cord Blood Banks and Private Cord Blood Banks for the Years 2020 & 2027
  • Table 27: Japan Current & Future Analysis for Umbilical Cord Blood Banking by Application - Cancers, Blood Disorders, Metabolic Disorders, Immune Disorders and Osteopetrosis - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
  • Table 28: Japan 7-Year Perspective for Umbilical Cord Blood Banking by Application - Percentage Breakdown of Value Sales for Cancers, Blood Disorders, Metabolic Disorders, Immune Disorders and Osteopetrosis for the Years 2020 & 2027
  • CHINA
  • Table 29: China Current & Future Analysis for Umbilical Cord Blood Banking by Storage - Public Cord Blood Banks and Private Cord Blood Banks - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
  • Table 30: China 7-Year Perspective for Umbilical Cord Blood Banking by Storage - Percentage Breakdown of Value Sales for Public Cord Blood Banks and Private Cord Blood Banks for the Years 2020 & 2027
  • Table 31: China Current & Future Analysis for Umbilical Cord Blood Banking by Application - Cancers, Blood Disorders, Metabolic Disorders, Immune Disorders and Osteopetrosis - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
  • Table 32: China 7-Year Perspective for Umbilical Cord Blood Banking by Application - Percentage Breakdown of Value Sales for Cancers, Blood Disorders, Metabolic Disorders, Immune Disorders and Osteopetrosis for the Years 2020 & 2027
  • EUROPE
  • Table 33: Europe Current & Future Analysis for Umbilical Cord Blood Banking by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR
  • Table 34: Europe 7-Year Perspective for Umbilical Cord Blood Banking by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2020 & 2027
  • Table 35: Europe Current & Future Analysis for Umbilical Cord Blood Banking by Storage - Public Cord Blood Banks and Private Cord Blood Banks - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
  • Table 36: Europe 7-Year Perspective for Umbilical Cord Blood Banking by Storage - Percentage Breakdown of Value Sales for Public Cord Blood Banks and Private Cord Blood Banks for the Years 2020 & 2027
  • Table 37: Europe Current & Future Analysis for Umbilical Cord Blood Banking by Application - Cancers, Blood Disorders, Metabolic Disorders, Immune Disorders and Osteopetrosis - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
  • Table 38: Europe 7-Year Perspective for Umbilical Cord Blood Banking by Application - Percentage Breakdown of Value Sales for Cancers, Blood Disorders, Metabolic Disorders, Immune Disorders and Osteopetrosis for the Years 2020 & 2027
  • FRANCE
  • Table 39: France Current & Future Analysis for Umbilical Cord Blood Banking by Storage - Public Cord Blood Banks and Private Cord Blood Banks - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
  • Table 40: France 7-Year Perspective for Umbilical Cord Blood Banking by Storage - Percentage Breakdown of Value Sales for Public Cord Blood Banks and Private Cord Blood Banks for the Years 2020 & 2027
  • Table 41: France Current & Future Analysis for Umbilical Cord Blood Banking by Application - Cancers, Blood Disorders, Metabolic Disorders, Immune Disorders and Osteopetrosis - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
  • Table 42: France 7-Year Perspective for Umbilical Cord Blood Banking by Application - Percentage Breakdown of Value Sales for Cancers, Blood Disorders, Metabolic Disorders, Immune Disorders and Osteopetrosis for the Years 2020 & 2027
  • GERMANY
  • Table 43: Germany Current & Future Analysis for Umbilical Cord Blood Banking by Storage - Public Cord Blood Banks and Private Cord Blood Banks - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
  • Table 44: Germany 7-Year Perspective for Umbilical Cord Blood Banking by Storage - Percentage Breakdown of Value Sales for Public Cord Blood Banks and Private Cord Blood Banks for the Years 2020 & 2027
  • Table 45: Germany Current & Future Analysis for Umbilical Cord Blood Banking by Application - Cancers, Blood Disorders, Metabolic Disorders, Immune Disorders and Osteopetrosis - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
  • Table 46: Germany 7-Year Perspective for Umbilical Cord Blood Banking by Application - Percentage Breakdown of Value Sales for Cancers, Blood Disorders, Metabolic Disorders, Immune Disorders and Osteopetrosis for the Years 2020 & 2027
  • ITALY
  • Table 47: Italy Current & Future Analysis for Umbilical Cord Blood Banking by Storage - Public Cord Blood Banks and Private Cord Blood Banks - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
  • Table 48: Italy 7-Year Perspective for Umbilical Cord Blood Banking by Storage - Percentage Breakdown of Value Sales for Public Cord Blood Banks and Private Cord Blood Banks for the Years 2020 & 2027
  • Table 49: Italy Current & Future Analysis for Umbilical Cord Blood Banking by Application - Cancers, Blood Disorders, Metabolic Disorders, Immune Disorders and Osteopetrosis - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
  • Table 50: Italy 7-Year Perspective for Umbilical Cord Blood Banking by Application - Percentage Breakdown of Value Sales for Cancers, Blood Disorders, Metabolic Disorders, Immune Disorders and Osteopetrosis for the Years 2020 & 2027
  • UNITED KINGDOM
  • Table 51: UK Current & Future Analysis for Umbilical Cord Blood Banking by Storage - Public Cord Blood Banks and Private Cord Blood Banks - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
  • Table 52: UK 7-Year Perspective for Umbilical Cord Blood Banking by Storage - Percentage Breakdown of Value Sales for Public Cord Blood Banks and Private Cord Blood Banks for the Years 2020 & 2027
  • Table 53: UK Current & Future Analysis for Umbilical Cord Blood Banking by Application - Cancers, Blood Disorders, Metabolic Disorders, Immune Disorders and Osteopetrosis - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
  • Table 54: UK 7-Year Perspective for Umbilical Cord Blood Banking by Application - Percentage Breakdown of Value Sales for Cancers, Blood Disorders, Metabolic Disorders, Immune Disorders and Osteopetrosis for the Years 2020 & 2027
  • REST OF EUROPE
  • Table 55: Rest of Europe Current & Future Analysis for Umbilical Cord Blood Banking by Storage - Public Cord Blood Banks and Private Cord Blood Banks - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
  • Table 56: Rest of Europe 7-Year Perspective for Umbilical Cord Blood Banking by Storage - Percentage Breakdown of Value Sales for Public Cord Blood Banks and Private Cord Blood Banks for the Years 2020 & 2027
  • Table 57: Rest of Europe Current & Future Analysis for Umbilical Cord Blood Banking by Application - Cancers, Blood Disorders, Metabolic Disorders, Immune Disorders and Osteopetrosis - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
  • Table 58: Rest of Europe 7-Year Perspective for Umbilical Cord Blood Banking by Application - Percentage Breakdown of Value Sales for Cancers, Blood Disorders, Metabolic Disorders, Immune Disorders and Osteopetrosis for the Years 2020 & 2027
  • ASIA-PACIFIC
  • Table 59: Asia-Pacific Current & Future Analysis for Umbilical Cord Blood Banking by Storage - Public Cord Blood Banks and Private Cord Blood Banks - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
  • Table 60: Asia-Pacific 7-Year Perspective for Umbilical Cord Blood Banking by Storage - Percentage Breakdown of Value Sales for Public Cord Blood Banks and Private Cord Blood Banks for the Years 2020 & 2027
  • Table 61: Asia-Pacific Current & Future Analysis for Umbilical Cord Blood Banking by Application - Cancers, Blood Disorders, Metabolic Disorders, Immune Disorders and Osteopetrosis - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
  • Table 62: Asia-Pacific 7-Year Perspective for Umbilical Cord Blood Banking by Application - Percentage Breakdown of Value Sales for Cancers, Blood Disorders, Metabolic Disorders, Immune Disorders and Osteopetrosis for the Years 2020 & 2027
  • REST OF WORLD
  • Table 63: Rest of World Current & Future Analysis for Umbilical Cord Blood Banking by Storage - Public Cord Blood Banks and Private Cord Blood Banks - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
  • Table 64: Rest of World 7-Year Perspective for Umbilical Cord Blood Banking by Storage - Percentage Breakdown of Value Sales for Public Cord Blood Banks and Private Cord Blood Banks for the Years 2020 & 2027
  • Table 65: Rest of World Current & Future Analysis for Umbilical Cord Blood Banking by Application - Cancers, Blood Disorders, Metabolic Disorders, Immune Disorders and Osteopetrosis - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
  • Table 66: Rest of World 7-Year Perspective for Umbilical Cord Blood Banking by Application - Percentage Breakdown of Value Sales for Cancers, Blood Disorders, Metabolic Disorders, Immune Disorders and Osteopetrosis for the Years 2020 & 2027

IV. COMPETITION
  • Total Companies Profiled: 42
Note: Product cover images may vary from those shown

A selection of companies mentioned in this report includes:

  • CBR Systems, Inc.
  • China Cord Blood Corporation
  • Cord Blood America, Inc.
  • CordLife Group Ltd.
  • Cryo-Cell International, Inc.
  • Cryo-Save AG
  • LifeCell International Pvt. Ltd.
  • StemCyte Inc.
  • ViaCord
  • Vita 34 AG
Note: Product cover images may vary from those shown